ArticleInternational journal of cardiology. Heart & vasculature2025
Prediction of spontaneous echo contrast following mitral valve transcatheter edge-to-edge repair.
Article in International journal of cardiology. Heart & vasculature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond multivalvular disease: imaging-guided diagnosis and management of combined functional mitral and tricuspid regurgitation.European heart journal. Imaging methods and practice · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although no studies predict thrombotic events after mitral valve transcatheter edge-to-edge repair (MV-TEER), 34% of patients experience worsening spontaneous echocardiographic contrast (SEC) following MV-TEER. We hypothesized that predicting the SEC occurrence or rapid progression after MV-TEER and identifying associated cases would be valuable. Methods: This retrospective study included 176 consecutive patients who underwent MV-TEER at Hiroshima University Hospital. SEC worsening was assessed using intraoperative transesophageal echocardiography pre- and post-procedure. Results: The study analyzed 168 patients undergoing MV-TEER (median age 80, 56 % male). Severe mitral regurgitation (MR), secondary MR, and atrial fibrillation were present in 67.5 %, 70.2 %, and 57.7 % (36.9 % paroxysmal) of patients, respectively. Overall, 149 patients (88 %) and 19 (12 %) had SEC grade ≤ 2 and SEC grade ≥ 3, respectively, considerably worsening post-MV-TEER in 30 %. Severe SEC or sludge (11 %) correlated with higher rates of non-paroxysmal atrial fibrillation (AF), cardiomyopathy, increased right atrial area index (RAAI), elevated atrial pressures, and reduced cardiac index. Multivariate analysis identified non-paroxysmal AF, RAAI, and preoperative SEC grade ≥ 3 as key predictors of severe SEC or sludge. Rapid SEC worsening (15 cases) was associated with non-paroxysmal AF, reduced left atrial strain, larger RAAI, and lower cardiac index. A predictive scoring model incorporating RAAI, left atrial strain, and cardiac index showed good discrimination (area under the curve: 0.79), aiding risk assessment for post-MV-TEER SEC progression. Conclusions: Patients with non-paroxysmal AF, right atrial enlargement, reduced left atrial reservoir strain, or low cardiac index are at risk of rapid SEC worsening after MV-TEER, regardless of initial SEC grades.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.